Altered calpastatin protein levels following traumatic brain injury in rat

Journal of Neurotrauma

Volumn 16, Issue 1, 1999, Pages 1-11

  Newcomb, Jennifer K ^a   Pike, Brian R ^a   Zhao, Xiurong ^a   Banik, Naren L ^b   Hayes, Ronald L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Calpain; Calpastatin; Central nervous system; Rat; Traumatic brain injury

Indexed keywords

CALPAIN; CALPASTATIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; BRAIN LEVEL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT;

EID: 0032948749     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1999.16.1     Document Type: Article

References (56)

1. ASADA, K., ISHINO, Y., SHIMADA, M., et al. (1989). cDNA cloning of human calpastatin: sequence homology among human, pig, and rabbit calpastatins. J. Enzym. Inhib. 3, 49-56.
2. BANIK, N.L., CHAKRABARTI, A.K., and HOGAN, E.L. (1990). Purification of an endogenous 68-kD inhibitor of calcium-activated neutral proteinase (CANP) from bovine brain: immunoblot identification and characterization. J. Neurosci. Res. 25, 119-124.
3. BANIK, N.L., MATZELLE, D.C., GANTT-WILFORD, G., OSBORNE, A., and HOGAN, E.L. (1997). Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752, 301-306.
4. BARTUS, R.T. (1997). The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway. Neuroscientist 3, 314-327.
5. CROALL, D.E., and DEMARTINO, G.N. (1991). Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 71, 813-847.
6. DEMARTINO, G.N., and CROALL, D.E. (1984). Purification and characterization of a protein inhibitor of calcium-dependent proteases from rat liver. Arch. Biochem. Biophys. 232, 713-720.
7. DETULLIO, R., SPARATORE, B., SALAMINO, F., MELLONI, E., and PONTREMOLI, S. (1998). Rat brain contains multiple mRNAs for calpastatin. F.E.B.S. Lett. 422, 113-117.
8. DIXON, C.E., CLIFTON, G.L., LIGHTHALL, J.W., YAGHMAI, A.A., and HAYES, R.L. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253-262.
9. ELDADAH, B.A., YAKOVLEV, A.G., and FADEN, A.I. (1997). The role of CED-3 related cysteine proteases in apoptosis of cerebellar granule cells. J. Neurosci. 17, 6105-6113.
10. EMORI, Y., KAWASAKI, H., IMAJOU, K., IMAHORI, K., and SUZUKI, K. (1987). Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc. Natl. Acad. Sci. U.S.A. 84, 3590-3594.
11. 45Ca autoradiographic study. Brain Res 624, 94-102.
12. FRASER, A., and EVAN, G. (1996). A license to kill. Cell 85, 781-784.
13. GRYNSPAN, F., GRIFFIN, W.B., MOHAN, P.S., SHEA, T.B., and NIXON, R.A. (1997). Calpains and calpastatin in SH-SY5Y neuroblastoma cells during retinoic acid-induced differentiation and neunte outgrowth: comparison with the human brain calpain system. J. Neurosci. Res. 48, 181-191.
14. INAZAWA, J., NAKAGAWA, H., MISAWA, S., et al. (1990). Assignment of the human calpastatin gene (CAST) to chromosome 5 at region q14-q22. Cytogenet. Cell Genet. 54, 156-158.
15. INOMATA, M., HAYASHI, M., NAKAMURA, M., SAITO, Y., and KAWASHIMA, S. (1989). Properties of erythrocyte membrane binding and autolytic activation of calcium-activated neutral protease. J. Biol. Chem. 264, 18838-18843.
16. INOMATA, M., NAKAMURA, M., IMAJOH-OHMI, S., and KAWASHIMA, S. (1993). A variety of calpain/calpastatin systems in mammalian erythrocytes. Biochim. Biophys. Acta 1178, 207-214.
17. KAMPFL, A., POSMANTUR, R., NIXON, R., et al. (1996). μ-Calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J. Neurochem. 67, 1575-1583.
18. KAMPFL, A., POSMANTUR, R.M., ZHAO, X., SCHMUTZHARD, E., CLIFTON, G.L., and HAYES, R.L. (1997). Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update. J. Neurotrauma 14, 121-134.
19. KAWASAKI, H., EMORI, Y., and SUZUKI, K. (1993). Calpastatin has two distinct sites for interaction with calpain-effect of calpastatin fragments on the binding of calpain to membranes. Arch. Biochem. Biophys. 305, 467-472.
20. LEE, W.J., MA, H., TAKANO, E., YANG, H.Q., HATANAKA, M., and MAKI, M. (1992). Molecular diversity in amino-terminal domains of human calpastatin by exon slapping. J. Biol. Chem. 267, 8437-8442.
21. MAKI, M., BAGCI, H., HAMAGUCHI, K., UEDA, M., MURACHI, T., and HATANAKA, M. (1989). Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J. Biol. Chem. 264, 18866-18869.
22. MELLGREN, R.L., MERICLE, M.T., and LANE, R.D. (1986). Proteolysis of the calcium-dependent protease inhibitor by myocardial calcium-dependent protease. Arch. Biochem. Biophys. 246, 233-239.
23. MIURA, M., ZHU, H., ROTELLO, R., HARTWIEG, E.A., and YUAN, J. (1993). Induction of apoptosis in fibroblasts by IL-1 beta converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660.
24. MOHAN, P.S., and NIXON, R.A. (1995). Purification and properties of high molecular weight calpastatin from bovine brain. J. Neurochem. 64, 859-866.
25. NAGAO, S., SAIDO, T.C., AKITA, Y., TSUCHIYA, T., SUZUKI, K., and KAWASHIMA, S. (1994). Calpain-calpastatin interactions in epidermoid carcinoma KB cells. J. Biochem. 115, 1178-1184.
26. NEUMAR, R.W., HAGLE, S.M., DEGRACIA, D.J., KRAUSE, G.S., and WHITE, B.C. (1996). Brain mu-calpain autolysis during global cerebral ischemia. J. Neurochem. 66, 421-424.
27. NEWCOMB, J.K., KAMPFL, A., POSMANTUR, R.M., et al. (1997). Immunohistochemical study of calpain-mediated breakdown products to α-spectrin following controlled cortical impact injury in the rat. J. Neurotrauma 14, 369-383.
28. NIXON, R.A., SAITO, K.-I., GRYNSPAN, F., et al. (1994). Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. N.Y. Acad. Sci. 747, 77-91.
29. OSTWALD, K., HAGBERG, H., ANDINE, P., and KARLSSON, J.O. (1993). Upregulation of calpain activity in neonatal rat brain after hypoxic-ischemia. Brain Res. 630, 289-294.
30. OSTWALD, K., HAYASHI, M., NAKAMURA, M., and KAWASHIMA, S. (1994). Subcellular distribution of calpan and calpastatin immunoreactivity and fodrin proteolysis in rabbit hippocampus after hypoxia and glucocorticoid treatment. J. Neurochem. 63, 1069-1076.
31. PIKE, B.R., ZHAO, X., NEWCOMB, J.K., POSMANTUR, R.M., WANG, K.K.W., and HAYES, R.L. (1998). Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport 9, 2437-2442.
32. PONTREMOLI, S., MELLONI, E., VIOTTI, P.L., MICHETTI, M., SALAMINO, F., and HORECKER, B.L. (1991). Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains. Arch. Biochem. Biophys. 288, 646-652.
33. POSMANTUR, R., HAYES, R.L., DIXON, C.E., and TAFT, W.C. (1994). Neurofilament 68 and neurofilament 200 protein levels decrease after TBI. J. Neurotrauma 11, 533-545.
34. POSMANTUR, R.M., KAMPFL, A., SIMAN, R., et al. (1997). A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental brain injury in the rat. Neuroscience 77, 875-888.
35. POSMANTUR, R.M., ZHAO, X., KAMPFL, A., CLIFTON, G.L., and HAYES, R.L. (1998). Immunoblot analysis of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats. Neurochem. Res. 23, 1265-1276.
36. ROBERTS-LEWIS, J.M., SAVAGE, M.J., MARCY, V.R., PINSKER, L.R., and SIMAN, R. (1994). Immunolocalization of μ-calpain-mediated spectrin degradation to vulnerable neurons in ischemic gerbil brain. J. Neurosci. 14, 3934-3944.
37. SAATMAN, K.E., BOZYCZKO-COYNE, D., MARCY, V., SIMAN, R., and McINTOSH, T.K. (1996a). Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 850-860.
38. SAATMAN, K.E., MURAI, H., BARTUS, R.T., et al. (1996b). Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. Natl. Acad. Sci. U.S.A. 93, 3428-3433.
39. SAIDO, T.C., KAWASHIMA, S., TANI, E., and YOKOTA, M. (1997). Up- and down-regulation of calpain inhibitor polypeptide, calpastatin, in postischemic hippocampus. Neurosci. Lett. 227, 75-78.
40. SAIDO, T.C., YOKOTA, M., NAGAO, S., et al. (1993). Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268, 25239-25243.
41. SHIELDS, D.C., and BANIK, N.L. (1998). Upregulation of calpain activity and expression in spinal cord of animals with experimental allergic encephalomyelitis (EAE): a putative role for calpain in demyelination. Brain Res. 794, 68-74.
42. SHIELDS, D.C., LEBLANC, C., and BANIK, N.L. (1997). Calcium-mediated neurofilament protein degradation in rat optic nerve in vitro: activity and autolysis of calpain proenzyme. Exp. Eye Res. 65, 15-21.
43. SORIMACHI, H., HARADA, K., SAIDO, T.C., ONO, T., KAWASHIMA, S.-I., and YOSHIDA, K.-I. (1997). Down-regulation of calpastatin in rat heart after brief ischemia and reperfusion. J. Biochem. 122, 743-748.
44. SPRINGER, J.E., AZBILL, R.D., KENNEDY, S.E., GEORGE, J., and GEDDES, J.W. (1997). Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury - attenuation with riluzole pretreatment. J. Neurochem. 69, 1592-1600.
45. SUZUKI, K., TSUJI, S., ISHIURA, S., KIMURA, Y., KUBOTA, S., and IMAHORI, K. (1981). Autolysis of calcium-activated neutral protease and chicken skeletal muscle. J. Biochem. 90, 1787-1793.
46. TAKANO, E., KITAHARA, A., SASAKI, T., KANNAGI, R., and MURACHI, T. (1986). Two different molecular species of pig calpastatin. Structural and functional relationship between 107-kDa and 68-kDa molecules. Biochem. J. 235, 97-102.
47. TAKANO, E., MAKI, M., MORI, H., et al. (1988). Pig heart calpastatin: identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis. Biochemistry 27, 1964-1972.
48. TOWBIN, H., STAEHELIN, T., and GORDON, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76, 4350-4354.
49. WANG, K.K.W., POSMANTUR, R., NADIMPALLI, R., et al. (1998). Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 356, 187-196.
50. YAKOVLEV, A.G., KNOBLACH, S.M., FAN, L., FOX, G.B., GOODNIGHT, R., and FADEN, A.I. (1997). Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17, 7415-7424.
51. YAMAURA, I., TANI, E., SAIDO, T.C., SUZUKI, K., MINAMI, N., and MAEDA, Y. (1993). Calpain-calpastatin system of canine basilar artery in vasospasm. J. Neurosurg. 79, 537-543.
52. YOKOTA, M., SAIDO, T.C., TANI, E., KAWASHIMA, S., and SUZUKI, K. (1995). Three distinct phases of fodrin proteolysis induced in postischemic hippocampus: involvement of calpain and unidentified proteases. Stroke 26, 1901-1907.
53. YOSHIDA, K.-I., SORIMACHI, Y., FUJIWARA, M., and HIRONAKA, K. (1995). Calpain is implicated in rat myocardial injury after ischemia or reperfusion. Jpn. Circ. J. 59, 40-48.
54. YUEN, P.W., and WANG, K.K.W. (1996). Therapeutic potential of calpain inhibitors in neurodegeneative disorders. Exp. Opin. Invest. Drugs 5, 1291-1304.
55. ZHAO, X., NEWCOMB, J.K., POSMANTUR, R.M., WANG, K.K.W., PIKE, B.R., and HAYES, R.L. (1998a). pH dependency of μ-calpain and m-calpain activity assayed by casein zymography following traumatic brain injury in the rat. Neurosci. Lett. 247, 53-57.
56. ZHAO, X., POSMANTUR, R., KAMPFL, A., et al. (1998b). Subcellular localization and duration of μ-calpain and m-calpain activity following TBI in the rat: a casein zymography study. J. Cereb. Blood Flow Metab. 18, 161-167.